ReAct 2026

ReAct 2026: Six focus areas

As 2025 draws to an end, ReAct celebrates 20 years of action, policy influence, and community mobilization in the work against antibiotic resistance. Looking ahead, 2026 is positioned as a pivotal year to translate political commitments- secured in 2024 and maintained through 2025 – into concrete action and sustained resources on the ground, particularly in low- and middle-income countries.

The year ahead opens up for further action to transform political promises into measurable impact across governance & financing, advancing National Action Plan implementation and equitable access to antibiotics.

News

ReAct Latin America at global AMR Summit in Costa Rica

From January 26 to 29, the final global convening of the “Just Transitions for AMR” group took place at the Tropical Agricultural Research and Higher Education Centre (CATIE) in Costa Rica. This international event was organized within the framework of the British Academy’s Global Convening Program 2026, in coordination with the University of Oxford.

ReAct Latin America contributed with community-led solutions to the meeting.

Reflections from the EU JAMRAI2 Annual Meeting

More than 35,000 people die each year in the EU/EEA as a result of infections caused by antibiotic-resistant bacteria, highlighting a growing threat that reflects global trends.

In this context, the EU Joint Action on Antimicrobial Resistance (EU JAMRAI 2) held a meeting at the end of January, bringing together representatives from EU Member States, Norway, Iceland, Ukraine, and more than 130 partner organizations worldwide.

Click to  read reflections from Anna Sjöblom, Director ReAct Europe, who participated in the meeting days.

Policy brief

Faith Based Organizations: Critical allies for stronger action on AMR

A new policy brief launched during a High-Level global dialogue underscores the indispensable role of faith-based organizations in addressing antimicrobial resistance, one of the most urgent and complex public health threats of our time. Convened by the World Council of Churches, the dialogue brought together global health leaders, policymakers, and faith actors to explore how trusted community institutions can help strengthen AMR prevention, stewardship, and advocacy – particularly across Africa.

Report

From Declaration to Action: Insights from the ReAct Asia Pacific 2025 Conference Report

Although global policy commitments and technical knowledge have expanded significantly, a persistent gap remains between political declarations and effective implementation. Bridging this gap requires sustained platforms that enable interdisciplinary dialogue, knowledge exchange, and collaborative governance across sectors and regions.

In this context, ReAct Asia Pacific organized a regional meeting September 2025, now you can learn more about the days and access the meeting report.

THEME

Antibiotic resistance and aquaculture: Why It matters for One Health

Aquaculture supplies more than half of the world’s seafood and plays a critical role in food security, livelihoods, and nutrition – particularly in low- and middle-income countries.

Yet the rapid expansion and intensification of fish and shrimp farming has also brought growing challenges, including infectious disease outbreaks and the widespread use of antibiotics.

These dynamics make aquaculture a key, and often under-addressed, front in the global action to contain antibiotic resistance, and more broadly, antimicrobial resistance.

Policy brief release

Unlocking AMR Financing: Optimizing international resources for an accelerated response to antibiotic resistance

A new ReAct analysis and policy brief highlights persistent barriers that hinder countries from optimally accessing and using international financing to implement their National Action Plans on Antimicrobial Resistance. It also identifies opportunities to make global AMR financing more coherent, efficient, and accessible, and outlines pathways to strengthen global mechanisms for more coordinated and effective AMR funding.

Interview

3 questions to ZDOROVI – ReAct’s new partner in Ukraine

Nataliia Tulinova, founder and CEO of ZDOROVI, has guided the organization through one of the most challenging periods in modern healthcare. In this interview, she shares her perspective why antimicrobial resistance and infection prevention and control are critical priorities. ReAct and ZDOROVI is joining forces with other European partners to strengthen infection control and prevention capacities in Ukrainian hospitals.